These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 32935554)
1. Automated Insulin Delivery in Real Life (AID-IRL): Real-World User Perspectives on Commercial AID. Lewis D J Diabetes Sci Technol; 2022 Mar; 16(2):500-503. PubMed ID: 32935554 [TBL] [Abstract][Full Text] [Related]
2. How It Started, How It Is Going: The Future of Artificial Pancreas Systems (Automated Insulin Delivery Systems). Lewis D J Diabetes Sci Technol; 2021 Nov; 15(6):1258-1261. PubMed ID: 34218717 [TBL] [Abstract][Full Text] [Related]
3. A real-world study of user characteristics, safety and efficacy of open-source closed-loop systems and Medtronic 670G. Jeyaventhan R; Gallen G; Choudhary P; Hussain S Diabetes Obes Metab; 2021 Aug; 23(8):1989-1994. PubMed ID: 33999488 [TBL] [Abstract][Full Text] [Related]
4. Performance of an Automated Insulin Delivery System: Results of Early Phase Feasibility Studies. Christiansen M; Bartee A; Lalonde A; Jones RE; Katz M; Wolpert H; Brazg R Diabetes Technol Ther; 2021 Mar; 23(3):187-194. PubMed ID: 32940537 [No Abstract] [Full Text] [Related]
5. Development and Future of Automated Insulin Delivery (AID) Systems. Garg SK; McVean JJ Diabetes Technol Ther; 2024 Mar; 26(S3):1-6. PubMed ID: 38377322 [No Abstract] [Full Text] [Related]
6. The Artificial Pancreas and Type 1 Diabetes. Nwokolo M; Hovorka R J Clin Endocrinol Metab; 2023 Jun; 108(7):1614-1623. PubMed ID: 36734145 [TBL] [Abstract][Full Text] [Related]
7. Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery System. Suttiratana SC; Wong JJ; Lanning MS; Dunlap A; Hanes SJ; Hood KK; Lal RA; Naranjo D Diabetes Technol Ther; 2022 Jun; 24(6):416-423. PubMed ID: 35099278 [No Abstract] [Full Text] [Related]
8. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes. Rodbard D Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879 [TBL] [Abstract][Full Text] [Related]
9. Automated insulin delivery systems: from early research to routine care of type 1 diabetes. Renard E Acta Diabetol; 2023 Feb; 60(2):151-161. PubMed ID: 35994106 [TBL] [Abstract][Full Text] [Related]
10. Do-It-Yourself and Commercial Automated Insulin Delivery Systems in Type 1 Diabetes: An Uncertain Area for Canadian Health-care Providers. Morrison AE; Senior PA; Bubela T; Farnsworth K; Witteman HO; Lam A Can J Diabetes; 2022 Dec; 46(8):863-870. PubMed ID: 35945126 [TBL] [Abstract][Full Text] [Related]
11. Do-It-Yourself Artificial Pancreas Systems: A Review of the Emerging Evidence and Insights for Healthcare Professionals. Jennings P; Hussain S J Diabetes Sci Technol; 2020 Sep; 14(5):868-877. PubMed ID: 31847570 [TBL] [Abstract][Full Text] [Related]
12. [What is the current state of the artificial pancreas in diabetes care?]. Dimou M; Laimer M; Stettler C; Bally L Internist (Berl); 2020 Jan; 61(1):102-109. PubMed ID: 31863132 [TBL] [Abstract][Full Text] [Related]
13. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance. Ly TT; Weinzimer SA; Maahs DM; Sherr JL; Roy A; Grosman B; Cantwell M; Kurtz N; Carria L; Messer L; von Eyben R; Buckingham BA Pediatr Diabetes; 2017 Aug; 18(5):348-355. PubMed ID: 27191182 [TBL] [Abstract][Full Text] [Related]